Invitations for screening appointments are usually issued every three years to individuals aged between 50 and 71 ...

Anyone over the age of 53 who believes they are due an appointment should get in touch with their local screening office ...

Anyone over the age of 53 who believes they are due an appointment should get in touch with their local screening office ...

Their findings led breast cancer specialist Professor Michael Baum to brand the NHS service 'unethical'. Professor Baum, Emeritus Professor of Surgery at University College Hospital, London ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

A "huge breakthrough" in breast cancer ... quick approval of breast cancer drugs so they can be made available promptly to those who need them,” she said. “NHS England must now put in place ...

Claire Rowney, chief executive at Breast Cancer Now, said: “We’re delighted that NICE has recommended capivasertib with fulvestrant for use on the NHS in England, offering certain people ...

despite Nice and NHS England offering unprecedented flexibilities in negotiations. “Enhertu is the first breast cancer treatment that Nice has been unable to recommend in over six years ...

A PILL which is taken twice a day for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a "landmark moment". Up to 3,000 women every year could ...